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Abstract 
PKC inhibitors are useful tools for studying PKC-dependent regulation of ion channels. 
For this purpose high PKC specificity is a basic requirement excluding any direct 
interaction between the PKC inhibitor and the ion channel. In the present study the 
effects of two frequently applied PKC inhibitors, chelerythine and bisindolylmaleimide I, 
were studied on the rapid and slow components of the delayed rectifier K+ current (IKr 
and IKs) in canine ventricular cardiomyocytes and on hERG channels expressed in HEK 
cells. Whole cell version of the patch clamp technique was used in all experiments. 
Chelerythrine and bisindolylmaleimide I (both 1 µM) suppressed IKr in canine ventricular 
cells. This inhibition developed rapidly suggesting a direct drug-channel interaction. In 
HEK cells heterologously expressing hERG channels, chelerythrine and 
bisindolylmaleimide I blocked hERG current in a concentration-dependent manner, 
having EC50 values of 0.11±0.01 and 0.76±0.04 µM, respectively. Both chelerythrine and 
bisindolylmaleimide I strongly modified gating kinetics of hERG: voltage-dependence of 
activation was shifted towards more negative voltages and activation was accelerated. 
Deactivation was slowed by bisindolylmaleimide I but not by chelerythrine. IKs was not 
significantly altered by bisindolylmaleimide I and chelerythrine. No significant effect of 
0.1 µM bisindolylmaleimide I or 0.1 µM PMA (PKC activator) was observed on IKr 
arguing against significant contribution of PKC to regulation of IKr. It is concluded that 
neither chelerythrine, nor bisindolylmaleimide I is suitable for selective PKC blockade 
due to their direct blocking actions on the hERG channel. 
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Introduction 
Delayed rectifier K+ currents play pivotal role in repolarization of the cardiac action 
potential. In the ventricular myocardium of most mammalian species, including dog and 
human, delayed rectifier K+ current is composed of two independent components, called 
IKr and IKs (Gintant 1996, Li et al. 1996). Both components are known to be under the 
control of the cAMP/PKA pathway, while the role of PKC in regulation of IKr and IKs is 
controversial, and therefore, poorly understood in spite of the extensive investigations of 
the field (Tohse 1990, Kathöfer et al. 2003, Xiao et al. 2003, Thomas et al. 2003, Thomas 
et al. 2004a, Toda et al. 2007, Matavel and Lopes 2009). Appropriate approach of this 
problem might be the application of selective PKC inhibitors, provided that these agents 
fail to interact directly with the ion channels mediating delayed rectifier K+ currents. 
These conditions, however, have never been controlled, except for an early study 
demonstrating that IKr was directly blocked by bisindolylmaleimide I in guinea pig 
ventricular cells (Thomas et al. 2004b). The aim of the present work was to study the 
effects of two frequently used PKC inhibitors, chelerythrine and bisindolylmaleimide I, 
on the rapid and slow components of the delayed rectifier K+ current (IKr and IKs) in 
ventricular cardiomyocytes of the dog, a species having action potential characteristics 
and properties of the underlying transmembrane ion currents most resembling the human 
(Szentandrássy et al. 2005, Szabó et al. 2005). Direct effects of the compounds were 
tested in an expression system containing hERG channels not coupled to signal 
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transduction pathways. It was found that both chelerythrine and bisindolylmaleimide I 
caused direct blockade of IKr – but not IKs – indicating that these drugs are not suitable to 
study the contribution of the PKC system to physiological regulation of IKr. 
 
Materials and methods 
Experiments with isolated canine cardiomyocytes 
Single canine ventricular myocytes were obtained from hearts of adult beagle dogs using 
the segment perfusion technique (Magyar et al. 2000). The animals (10-14 kg) were 
anesthetized with i.v. injection of 10 mg/kg ketamine hydrochloride (Calypsol, Richter 
Gedeon, Hungary) + 1 mg/kg xylazine hydrochloride (Sedaxylan, Eurovet Animal Health 
BV, The Netherlands). After opening the chest the heart was rapidly removed and the left 
anterior descending coronary artery was perfused using a Langendorff apparatus. Ca2+-
free JMM solution (Minimum Essential Medium Eagle, Joklik modification, Sigma), 
supplemented with taurine (2.5 g/l), pyruvic acid (175 mg/l), ribose (750 mg/l), 
allopurinol (13.5 mg/l) and NaH2PO4 (200 mg/l), was used during the initial 5 min of 
perfusion to remove Ca2+ and blood from the tissue. After addition of NaHCO3 (1.3 g/l) 
the pH of this perfusate was adjusted to 6.9 by equilibrating the solution with a mixture 
of 95% O2 and 5% CO2. Cell dispersion was performed for 30 min in the same solution 
containing also collagenase (660 mg/l, Worthington CLS-II), bovine albumin (2 g/l) and 
CaCl2 (50 µM). During the isolation procedure the solutions were gassed with carbogen 
and the temperature was maintained at 37 oC. The cells were rod shaped and showed 
clear striation when the external calcium was restored. 
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 IKr and IKs were recorded at 37 oC from Ca2+-tolerant canine ventricular cells 
superfused with Tyrode solution containing (in mM) NaCl 140, KCl 5.4, CaCl2 2.5, 
MgCl2 1.2, HEPES 5, glucose 10, at pH 7.4. This superfusate was supplemented with 5 
µM nifedipine plus 1 µM E-4031 when measuring IKs, or 5 µM nifedipine plus 1 µM 
HMR-1556 in case of recording IKr, in order to eliminate L-type Ca2+ current, IKr, or IKs, 
respectively. Suction pipettes, fabricated from borosilicate glass, had tip resistances of 
1.5-2 MΩ after filling with pipette solution composed of (in mM) K-aspartate 100, KCl 
45, MgCl2 1, HEPES 5, EGTA 10, K-ATP 3. The pH of this solution was adjusted to 7.2 
with KOH. Membrane currents were recorded with an Axopatch-200B amplifier (Axon 
Instruments) using the whole cell configuration of the patch clamp technique. After 
establishing high (1-10 GΩ) resistance seal by gentle suction, the cell membrane beneath 
the tip of the electrode was disrupted by further suction or by applying 1.5 V electrical 
pulses for 1 ms. Ion currents were normalized to cell capacitance, determined in each cell 
using short hyperpolarizing pulses from -10 mV to -20 mV. The series resistance was 
typically 4-8 MΩ before compensation (usually 50-80%) prior to the measurement. 
Experiments were discarded when the amplitude of IKr or IKs was unstable within the 
initial 5 min of the experiment, or the series resistance was high or increased during the 
measurement. Outputs from the clamp amplifier were digitized at 20 kHz using an A/D 
converter (Digidata-1200, Axon Instruments) under software control (pClamp 6.0, Axon 
Instruments). 
 
hERG current measurements in transfected human embryonic kidney cells 
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hERG channels were expressed in a stable manner in a HEK-293 cell line. Cells were 
grown in Dulbecco’s minimum essential medium–high glucose supplemented with 10 % 
FBS, 2 mM L-glutamine, 0.11 mg/ml Na-pyruvate, 100 U/ml penicillin-G, 0.1 mg/ml 
streptomycin (Invitrogen), 5 ml Non-essential Amino Acid (Sigma-Aldrich) at 37 ○C in a 
5% CO2 and 95% air-humidified atmosphere. 
Whole-cell currents were measured in voltage-clamped cells using Axopatch 
200A amplifiers connected to a personal computer using Axon Digidata 1200 data 
acquisition hardware (Molecular Devices Inc., Sunnyvale, CA). Series resistance 
compensation up to 70 % was used to minimize voltage errors and achieve good voltage-
clamp conditions. Pipettes were pulled from GC 150 F-15 borosilicate glass capillaries in 
five stages and fire-polished, resulting in electrodes having 4–6 MΩ resistance in the 
bath. The bath solution contained (in mM) Choline-Cl 140, KCl 5, MgCl2 2, CaCl2 2, 
CdCl2 0.1, glucose 20, and HEPES 10, at pH = 7.35. The internal solution consisted of (in 
mM) KCl 140, EGTA 10, MgCl2 2, and HEPES 10, at pH = 7.3. Superfusion with 
different test solutions was achieved using a continuous perfusion system based on 
gravity-flow. For data acquisition and analysis, the pClamp software package was used. 
Currents were low-pass filtered using the built in analog 4-pole Bessel filters of the 
amplifiers and sampled at 2 kHz. Before analysis, whole-cell current traces were 
corrected for ohmic leakage and digitally filtered (three-point boxcar smoothing). 
 
All values presented are arithmetic means ± SEM. Statistical significance of differences 
was evaluated with using one-way ANOVA followed by Student's t test for paired or 
unpaired data, as pertinent. Differences were considered significant when the P value was 
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less than 0.05. The principles of laboratory animal care (NIH publication No. 85-23, 
revised 1985) and current version of the Hungarian Law on the Protection of Animals 
were strictly followed throughout the experiments. 
 
Results 
Effects of chelerythrine and bisindolylmaleimide I on IKr in canine ventricular myocytes 
IKr was activated by 250 ms depolarizing pulses to +10 mV applied at a rate of 0.05 Hz. 
IKr was characterized as tail current amplitudes determined as the difference of the peak 
current and the pedestal value observed following repolarization to the holding potential 
of -40 mV in the presence of 5 µM nifedipine plus 1 µM HMR-1556. These IKr current 
tails were fully eliminated by 1 µM E-4031 indicating that the current can be considered 
as pure IKr mediated by hERG channels. 
Exposure of myocytes to the PKC inhibitor bisindolylmaleimide I (1 µM) 
decreased IKr tail amplitude from 0.36±0.05 to 0.11±0.04 pA/pF (P<0.05, n=5, Figs. 1.A-
C). Similar results were obtained with another PKC inhibitor chelerythrine (1 µM), where 
IKr tail current decreased from 0.39±0.04 to 0.05±0.02 pA/pF (P<0.05, n=4, Figs. 1.D-F). 
IKr was fully eliminated by 10 µM chelerythrine (n=3, not shown). In both cases the 
blockade of IKr developed rapidly, the maximal effect was typically achieved within a 
few minutes (Figs. 1.B and 1.E). 
 
Effects of chelerythrine and bisindolylmaleimide I on hERG current in transfected HEK-
293 cells 
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hERG current was activated by depolarization to +30 mV for 3 s, which was followed by 
a repolarization to -40 mV allowing for relaxation of the current resulting tail current. 
Amplitude of the tail current was considered as an indicator of hERG current density. In 
these experiments the holding potential was set to -80 mV, pulses were delivered every 
30 s. Both PKC inhibitors, bisindolylmaleimide I and chelerythrine caused a 
concentration-dependent suppression of the hERG current (Fig. 2). This blockade was 
readily reversible in the case of bisindolylmaleimide I (Fig. 2.A) but only partially in the 
case of chelerythrine. Fitting data to the Hill equation the estimated EC50 values were 
0.76±0.04 and 0.11±0.01 µM for bisindolylmaleimide I and chelerythrine, respectively, 
with the corresponding Hill coefficient of 1.21±0.07 and 1.52±0.18 (n=4 for each drug). 
 Both bisindolylmaleimide I and chelerythrine modified the gating kinetics of 
hERG current (Fig. 3). Voltage-dependence of steady-state activation was obtained by 
measuring tail current amplitudes at -40 mV following test pulses clamped to various 
voltages indicated in abscissa. Each tail current was normalized to that obtained 
following the most positive test potential. The voltage-dependence of activation was 
shifted towards more negative voltages by the two PKC inhibitors. Half-activation 
voltage, determined by fitting data to the two-state Boltzmann model, was shifted from 
2.7±1.2 to -9.5±1.4 mV by 1 µM bisindolylmaleimide I and from 0.6±2.7 to -12.6±3.7 
mV by 0.1 µM chelerythrine (P<0.05, n=4 for each drug). No significant changes were 
observed in the corresponding slope factors: 7.4±0.4 versus 7.2±0.3 mV-1 and 7.7±0.6 
versus 8.1±0.5 mV-1, respectively (Figs. 3.A and 3.D). 
 Time-dependence of activation of hERG current was determined using the tail-
envelope test. Tail currents were recorded at -40 mV following test depolarizations (to 
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+30 mV) having increasing durations as shown in the abscissa. In the presence of 
bisindolylmaleimide I and chelerythrine the longest test pulse was 0.8 s, since activation 
was fully saturated by this time. Each tail current was normalized to that of the highest 
amplitude. Time constants for activation was determined by monoexponential fitting. 
Activation was accelerated by both compounds. Accordingly, the time constant of 
activation was reduced from 301±57 to 143± 22 ms and from 247±19 to 146±5 ms by 1 
µM bisindolylmaleimide I and 0.1 µM chelerythrine, respectively (P<0.05, n=4 for each 
drug, Figs. 3.B and 3.E). 
 Time constant of deactivation was measured at -40 mV following a 3 s long 
depolarization to +30 mV. Deactivation was determined as a sum of two exponential 
components characterized by fast and slow time constants (τ1, τ2) and the corresponding 
amplitudes (Α1, Α2). 1 µM bisindolylmaleimide I significantly increased the fast and slow 
time constants of deactivation, while 0.1 µM chelerythrine left these time constants 
unaffected as indicated by Figs. 3.C and 3.F. See also the insets presented in Figs. 2.A 
and 2.C.  
 
Possible role of PKC in regulation of IKr in canine ventricular cells 
Although the direct blockade of hERG current by chelerythrine and bisindolylmaleimide 
I was demonstrated above, the effect of PKC inhibition had to be also examined. In these 
experiments a lower (0.1 µM) concentration of bisindolylmaleimide I, blocking PKC 
effectively with relatively small direct blocking action on IKr, was used. The effect of 0.1 
µM bisindolylmaleimide I was tested using both low cytosolic Ca2+ concentration 
(buffered by 10 mM EGTA) and at high cytosolic Ca2+ level, where [Ca2+]i was set to 500 
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nM using the Fabiato program (Fabiato and Fabiato 1979). This was designed to 
distinguish between possible effects on the calcium-sensitive conventional and calcium-
insensitive novel PKC isoforms (Mellor and Parker 1998). As shown in Figs. 4.A and 4.B 
inhibition of PKC by 0.1 µM bisindolylmaleimide I failed to alter IKr tail amplitude 
significantly, which was independent of the actual level of Ca2+i. Similarly, IKr was not 
modified significantly by activation of PKC by 0.1 µM PMA in the presence of 0.5 µM 
cytosolic Ca2+ (Fig. 4.C). These results strongly suggest that PKC inhibition itself has 
little effect on the amplitude of IKr in canine ventricular cells. 
 
Effects of chelerythrine and bisindolylmaleimide I on IKs
For the sake of comparison, effects of the two PKC inhibitors were studied also on IKs. IKs 
was activated in the presence of 5 µM nifedipine plus 1 µM E-4031 by 3 s long 
depolarizing pulses to +30 mV delivered at a rate of 0.1 Hz from the holding potential of 
-40 mV. Tail currents, obtained after repolarization, were used to characterize IKs. The 
current was fully eliminated by 1 µM HMR-1556, indicating that it was pure IKs. 
Exposure of myocytes to bisindolylmaleimide I (1 µM) or chelererythrine (1 µM) 
caused small, statistically not significant, increases in IKs tail amplitudes: IKs was 
increased from 1.28±0.35 to 1.55±0.41 pA/pF (P=0.26, n=5) and from 1.26±0.23 to 
1.41±0.32 pA/pF (P=0.58, n=6), respectively (Fig. 5). 
 
Discussion 
In the present work the effects of two frequently used PKC inhibitors, chelerythine and 
bisindolylmaleimide I, were studied on the rapid and slow components of the delayed 
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rectifier K+ current (IKr and IKs) in canine ventricular cardiomyocytes. IKr – but not IKs – 
was strongly suppressed by both agents. Since the inhibitory effects of chelerythine and 
bisindolylmaleimide I were observed also in pure hERG channels expressed without co-
expression of the members of the PKC system in HEK cells, one may conclude that these 
drugs block IKr directly, i.e. independently of their PKC inhibiting potencies. This is 
further supported by the findings that (1) the effects of chelerythine and 
bisindolylmaleimide I developed rapidly, and (2) manipulation of the PKC system by 
PMA and low concentration of bisindolylmaleimide I failed to alter IKr significantly. 
Although bisindolylmaleimide I has been previously reported to block hERG current 
directly (Thomas et al. 2004b), we are first to report a direct inhibition of hERG current 
and canine IKr by another PKC inhibitor, chelerythrine. 
 In addition to their blocking action, chelerythine and bisindolylmaleimide I 
caused marked changes in gating kinetics of hERG current, including a negative shift in 
voltage-dependence of activation, acceleration of activation and slowing of deactivation 
(this latter was observed only with bisindolylmaleimide I). Since these kinetic changes 
are incopatible with current inhibition (they are actually congruent with enhancement of 
the current), the blocking effect of bisindolylmaleimide I and chelerythrine is likely based 
on a cork-in-the-bottle mechanism of open channel block rather than being related to the 
observed alterations in gating kinetics.  
  Direct inhibition of hERG channels is not an exceptional side-effect of PKC 
inhibitors. The hERG-inhibitor effect of bisindolylmaleimide I has been previously 
described by Thomas et al. (2004b) presenting results very congruent with ours. The EC50 
value obtained in HEK cells was 0.76 µM in our, while 1 µM in their experiments. 1 µM 
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bisindolylmaleimide I caused a 69.2 % inhibition in the native IKr of guinea pig (Thomas 
et al. 2004b) and a 69.4 % blockade of canine IKr (present study). An interesting 
difference between the results of the two studies can be observed in the kinetic properties 
of IKr blockade. We found a marked leftward shift of -12.2 mV in the voltage-dependence 
of IKr activation in the presence of bisindolylmaleimide I, while only a small, statistically 
not significant change of -2.9 mV was seen by Thomas et al. (2004b). The reason for this 
discrepancy is not clear at present, it might partly be caused by an improvement of 
voltage control due to reduction of hERG current amplitudes. However, a -20.3 mV 
leftward shift in steady-state inactivation was reported by Thomas et al. (2004b), which 
may in fact contribute to the bisindolylmaleimide I-induced IKr blockade. 
In addition to IKr blockade, both chelerythrine and bisindolylmaleimide I were 
shown to block voltage-activated K+ and Ca2+ channels in rat ventricular cells, which 
effect - similarly to our results – proved to be independent of PKC inhibition 
(Voutilainen-Myllyla et al. 2003). Acetylcholine-activated K+ current was also blocked 
by chelerythrine and bisindolylmaleimide I in murine atrial myocytes (Cho et al. 2001). 
Furthermore, bisindolylmaleimide I inhibited voltage-dependent K+ channels in arterial 
smooth muscle cells of rats and mice (Kim et al., 2004; Park et al. 2005), while another 
PKC inhibitor, staurosporine enhanced the activity of cardiac Na+/Ca2+ exchanger in a 
PKC-independent manner (Kang 2008). It would be interesting to know which part(s) of 
these molecules are responsible for their ionotropic actions, since proper modification of 
these groups might result PKC inhibitors with less intensive interactions with ion 
channels improving thus their specificity to PKC. 
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 Although the general conclusion of this work is that neither chelerythine nor 
bisindolylmaleimide I is really suitable for studying the contribution of PKC in regulation 
of cardiac delayed rectifier K+ channels, some cautious remarks on this point can be 
made. Low concentration (0.1 µM) of bisindolylmaleimide I, which is known to block 
PKC effectively, while was shown in Fig. 2.B to cause approximately 10 % inhibition of 
hERG current, failed to decrease IKr tail amplitudes in intact canine ventricular cells (as 
shown in Figs. 4.A and 4.B). In contrast, there was a mild tendency of current increase 
during the 30 min period of superfusion. Furthermore, activation of PKC by PMA tended 
to slightly decrease IKr (Fig. 4.C). Since the above mentioned changes were not 
significant statistically, they cannot be considered conclusive. The fact, however, that the 
10 % inhibition was not observed on canine IKr in the presence of 0.1 µM 
bisindolylmaleimide I suggests that PKC might moderately suppress IKr under control 
conditions, allowing thus the current to increase slightly upon inhibition of PKC. This is 
congruent with previous results on hERG channels expressed in Xenopus oocytes, where 
activation of the conventional PKC isoenzymes with thymelatoxin was shown to decrease 
IKr (Thomas et al. 2003). 
Similarly to results obtained with IKr, a moderate, but again statistically not 
significant, enhancement of IKs was observed after superfusion with 1 µM chelerythrine 
or bisindolylmaleimide I (Fig. 5). Regarding the role of PKC in controlling IKs the 
published observations are quite controversial and show strong interspecies differences. 
For instance, the activation of PKC was shown to enhance IKs in native cardiac cells of 
the guinea pig (Tohse et al. 1990, Heath and Terrar 2000, Toda et al. 2007) and in 
oocytes expressing human IKs channel proteins (Xiao et al. 2003, Kathöfer et al. 2003, 
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Matavel and Lopez 2009). In contrast, IKs was suppressed by PKC activation when the 
oocytes were tranfected with murine or rat IKs channels (Honoré et al. 1991, Busch et al. 
1992). Our results suggest that the PKC-dependent modulation of IKs in dog may be 
restricted to a moderate tonic inhibition, which can be suspended by blockade of the 
enzyme. It is interesting to note, that IKs was reduced by 20 % after superfusion with 
phenylephrine in canine myocytes (Robinson et al. 2000). This is in line with our 
findings, i.e. with the slight increase of IKs observed in the presence of PKC inhibitors 
(even if the difference failed to reach the level of statistical significance). 
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Figure legends 
 
Fig. 1.  Effects of the PKC inhibitor bisindolylmaleimide I (Bim I, A-C) and 
chelerythrine (D-F) on IKr in canine ventricular myocytes.  A, D: Representative 
superimposed IKr tails obtained before and after drug exposure. B, E: Time course of 
development of drug effects. C, F: Average IKr tail amplitudes in control and in the 
presence of 1 µM bisindolylmaleimide I (n=5) and 1 µM chelerythrine (n=4). Columns 
and bars indicate means ± SEM values, asterisks denote significant (P<0.05) differences 
from control values. 
 
Fig. 2.  Concentration-dependent effects of bisindolylmaleimide I (Bim I, A, B) and 
chelerythrine (C, D) on hERG current expressed in HEK-293 cells.  A, C: Representative 
traces showing superimposed hERG current records obtained in control, in the presence 
of cumulatively increasing concentrations of bisindolylmaleimide I or chelerythrine, as 
indicated, and following washout. Insets: IKr tail current tails obtained in the presence 1 
µM bisindolylmaleimide I and 0.1 µM chelerythrine were magnified so as their 
amplitudes should be identical to that of the corresponding control traces. B, D: 
Cumulative dose-response curves. Solid lines were obtained by fitting data to the Hill 
equation. Symbols and bars indicate means ± SEM values, collected from 4 cells with 
each drug. 
 
Fig. 3.  Effects of 1 µM bisindolylmaleimide I (Bim I) and 0.1 µM chelerythrine on the 
kinetic properties of hERG current.  A, D: Voltage-dependence of steady-state activation. 
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Results were fitted to the Boltzmann function to estimate the half-activation voltage 
(V0.5) and slope factor.  B, E: The time-dependence of activation of hERG current 
determined using the tail-envelope test. Solid lines were obtained by monoexponential 
fitting.  C, F: Deactivation of hERG current at -40 mV was determined as a sum of two 
exponential components characterized by a fast and a slow time constant (τ1 and τ2) and 
the corresponding amplitudes (Α1 and Α2). Symbols, columns and bars indicate means ± 
SEM values obtained in 4 cells with each drug, asterisks denote significant (P<0.05) 
differences from control. 
 
Fig. 4.  Time-dependent effects of low concentrations of bisindolylmaleimide I (Bim I) 
and PMA on IKr tail amplitude in canine ventricular cells. A: Effect of 0.1 µM 
bisindolylmaleimide I in the presence of low cytosolic calcium buffered by 10 mM 
EGTA in the pipette solution (n=6). B: Effect of 0.1 µM bisindolylmaleimide I in the 
presence of high (0.5 µM) cytosolic Ca2+ concentration set using the Fabiato program 
(n=5). C: Effect of 0.1 µM PMA in the presence of high cytosolic Ca2+ (n=5). IKr tails 
were normalized to their respective initial values. Symbols and bars are means ± SEM, 
dotted lines indicate the baseline level. 
 
Fig. 5.  Effects of bisindolylmaleimide I (A-C) and chelerythrine (D-F) on IKs in canine 
myocytes.  A, D: Representative superimposed IKs tails obtained before and after drug 
exposure. B, E: Time course of development of drug effects. C, F: Average IKs tail 
amplitudes in control and in the presence of 1 µM bisindolylmaleimide I (n=5) or 1 µM 
chelerythrine (n=6). Columns and bars indicate means ± SEM values. 
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